Non-Coding RNAs in Multiple Myeloma Bone Disease Pathophysiology.
Lavinia RaimondiAngela De LucaGianluca GiavaresiStefania RaimondoAlessia GalloElisa TaianaRiccardo AlessandroMarco RossiAntonino NeriGiuseppe VigliettoNicola AmodioPublished in: Non-coding RNA (2020)
Bone remodeling is uncoupled in the multiple myeloma (MM) bone marrow niche, resulting in enhanced osteoclastogenesis responsible of MM-related bone disease (MMBD). Several studies have disclosed the mechanisms underlying increased osteoclast formation and activity triggered by the various cellular components of the MM bone marrow microenvironment, leading to the identification of novel targets for therapeutic intervention. In this regard, recent attention has been given to non-coding RNA (ncRNA) molecules, that finely tune gene expression programs involved in bone homeostasis both in physiological and pathological settings. In this review, we will analyze major signaling pathways involved in MMBD pathophysiology, and report emerging evidence of their regulation by different classes of ncRNAs.
Keyphrases
- bone marrow
- bone loss
- bone mineral density
- multiple myeloma
- gene expression
- soft tissue
- mesenchymal stem cells
- randomized controlled trial
- bone regeneration
- signaling pathway
- stem cells
- dna methylation
- public health
- working memory
- body composition
- epithelial mesenchymal transition
- cell proliferation
- pi k akt
- inflammatory response